BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
morepen lab. ltd stock

MOREPEN LAB. LTD Share Price

87.13 -1.22 (-1.38%)
Dec 13 2024 03:30 PM Pharmaceuticals NSE: MOREPENLAB

MOREPEN LAB. LTD Share Price Update

As of the latest trading session, MOREPEN LAB. LTD share price is currently at 87.13, which is down by -1.22 from its previous closing. Today, the stock has fluctuated between 84.70 and 88.70. Over the past year, MOREPEN LAB. LTD has achieved a return of 95.57 %. In the last month alone, the return has been 15.35 %. Read More...

MOREPEN LAB. LTD Performance

Day Range

Low84.70 High88.70
87.13

52 Week Range

Low 38.55 High 100.90
87.13

MOREPEN LAB. LTD Share Price

2259

500288

MOREPENLAB

img img img img
No Data Available

Open Price

88.70

Prev. Close

88.35

Volume (Shares)

8888505.00

Total traded value

7744.55

Upper Circuit

106.02

Lower Circuit

70.68

Note: The current prices & values are delayed, Login to your account for live updates.

MOREPEN LAB. LTD Fundamentals


(Standalone)

Market Cap (Cr) 4453.81
PE Ratio (TTM) 33.64
Book Value / Share 20.95
Beta 1.40
ROE 13.29%
EPS (TTM) 2.59
Dividend Yield 0.00%
Net Profit Qtr (Cr) 31.93

MOREPEN LAB. LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 383.70
Operating Expense 345.48
Net Profit 31.93
Net Profit Margin (%) 8.32
Earnings Per Share (EPS) 0.60
EBITDA 47.69
Effective Tax Rate (%) 25.50
Particulars JUN 2024 (Values in Cr)
Revenue 385.64
Operating Expense 341.66
Net Profit 35.05
Net Profit Margin (%) 9.08
Earnings Per Share (EPS) 0.69
EBITDA 51.67
Effective Tax Rate (%) 25.50
Particulars MAR 2024 (Values in Cr)
Revenue 392.60
Operating Expense 343.88
Net Profit 39.96
Net Profit Margin (%) 10.17
Earnings Per Share (EPS) 0.78
EBITDA 60.12
Effective Tax Rate (%) 24.18
Particulars DEC 2023 (Values in Cr)
Revenue 394.63
Operating Expense 351.06
Net Profit 35.20
Net Profit Margin (%) 8.91
Earnings Per Share (EPS) 0.69
EBITDA 54.76
Effective Tax Rate (%) 25.45
Particulars SEP 2023 (Values in Cr)
Revenue 381.26
Operating Expense 356.76
Net Profit 19.92
Net Profit Margin (%) 5.22
Earnings Per Share (EPS) 0.39
EBITDA 32.58
Effective Tax Rate (%) 27.11
Particulars MAR 2024 (Values in Cr)
Book Value / Share 16.58
ROE % 12.08
ROCE % 16.12
Total Debt to Total Equity 0.03
EBITDA Margin 10.21
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.73
ROE % 5.81
ROCE % 8.02
Total Debt to Total Equity 0.03
EBITDA Margin 6.04
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.56
ROE % 20.27
ROCE % 21.70
Total Debt to Total Equity 0.04
EBITDA Margin 9.50
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.47
ROE % 25.85
ROCE % 20.94
Total Debt to Total Equity 0.21
EBITDA Margin 10.99
Particulars MAR 2020 (Values in Cr)
Book Value / Share 6.32
ROE % 10.24
ROCE % 8.48
Total Debt to Total Equity 0.49
EBITDA Margin 9.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.39
ROE % 13.29
ROCE % 17.08
Total Debt to Total Equity 0.03
EBITDA Margin 11.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.26
ROE % 6.71
ROCE % 8.78
Total Debt to Total Equity 0.03
EBITDA Margin 6.20
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.97
ROE % 19.38
ROCE % 20.85
Total Debt to Total Equity 0.03
EBITDA Margin 9.62
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.92
ROE % 24.43
ROCE % 19.57
Total Debt to Total Equity 0.21
EBITDA Margin 11.16
Particulars MAR 2020 (Values in Cr)
Book Value / Share 6.83
ROE % 9.86
ROCE % 8.04
Total Debt to Total Equity 0.48
EBITDA Margin 9.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 52.11
Total Assets 1293.20
Total Liabilities 1293.20
Total Equity 847.22
Share Outstanding 511168708
Price to Book Ratio 2.42
Return on Assets (%) 7.43
Return on Capital (%) 10.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 56.30
Total Assets 1110.49
Total Liabilities 1110.49
Total Equity 752.44
Share Outstanding 511168708
Price to Book Ratio 1.68
Return on Assets (%) 3.48
Return on Capital (%) 4.97
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 45.97
Total Assets 1070.05
Total Liabilities 1070.05
Total Equity 578.10
Share Outstanding 477826203
Price to Book Ratio 3.06
Return on Assets (%) 9.50
Return on Capital (%) 17.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 67.89
Total Assets 858.14
Total Liabilities 858.14
Total Equity 424.29
Share Outstanding 449826203
Price to Book Ratio 3.60
Return on Assets (%) 11.31
Return on Capital (%) 22
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 38.88
Total Assets 663.46
Total Liabilities 663.46
Total Equity 283.59
Share Outstanding 449793203
Price to Book Ratio 1.40
Return on Assets (%) 5.06
Return on Capital (%) 11.35
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 50.47
Total Assets 1279.30
Total Liabilities 1279.30
Total Equity 889.02
Share Outstanding 511168708
Price to Book Ratio 2.42
Return on Assets (%) 8.67
Return on Capital (%) 12.09
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 55.90
Total Assets 1105.54
Total Liabilities 1105.54
Total Equity 780.11
Share Outstanding 511168708
Price to Book Ratio 1.68
Return on Assets (%) 4.18
Return on Capital (%) 5.74
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 45.54
Total Assets 1033.26
Total Liabilities 1033.26
Total Equity 598.16
Share Outstanding 477826203
Price to Book Ratio 3.06
Return on Assets (%) 9.78
Return on Capital (%) 16.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 66.98
Total Assets 847.49
Total Liabilities 847.49
Total Equity 444.97
Share Outstanding 449793203
Price to Book Ratio 3.60
Return on Assets (%) 11.12
Return on Capital (%) 20.4
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 38.03
Total Assets 661.98
Total Liabilities 661.98
Total Equity 307.24
Share Outstanding 449793203
Price to Book Ratio 1.40
Return on Assets (%) 4.88
Return on Capital (%) 10.12
Particulars MAR 2024 (Values in Cr)
Net Income 135.41
Cash from Operations 111.48
Cash from Investing -83.30
Cash from Financing 5.20
Net change in Cash -4.72
Free Cash Flow 182.87
Particulars MAR 2023 (Values in Cr)
Net Income 55.75
Cash from Operations -74.61
Cash from Investing -46.50
Cash from Financing 143.54
Net change in Cash 5.86
Free Cash Flow -38.99
Particulars MAR 2022 (Values in Cr)
Net Income 126.70
Cash from Operations -35.30
Cash from Investing -31.67
Cash from Financing 66.33
Net change in Cash -25.58
Free Cash Flow 10.13
Particulars MAR 2021 (Values in Cr)
Net Income 98.51
Cash from Operations 52.28
Cash from Investing -70.35
Cash from Financing 47.27
Net change in Cash 27.74
Free Cash Flow 74.08
Particulars MAR 2020 (Values in Cr)
Net Income 39.10
Cash from Operations 16.89
Cash from Investing -12.46
Cash from Financing 5.48
Net change in Cash 4.04
Free Cash Flow 33.55
Particulars MAR 2024 (Values in Cr)
Net Income 148.97
Cash from Operations 114.72
Cash from Investing -83.60
Cash from Financing 0.28
Net change in Cash -5.95
Free Cash Flow 185.95
Particulars MAR 2023 (Values in Cr)
Net Income 63.04
Cash from Operations -85.84
Cash from Investing -36.19
Cash from Financing 144.19
Net change in Cash 5.88
Free Cash Flow -50.29
Particulars MAR 2022 (Values in Cr)
Net Income 125.54
Cash from Operations -44.47
Cash from Investing -22.64
Cash from Financing 66.41
Net change in Cash -25.09
Free Cash Flow 0.68
Particulars MAR 2021 (Values in Cr)
Net Income 94.24
Cash from Operations 49.31
Cash from Investing -69.08
Cash from Financing 47.46
Net change in Cash 27.68
Free Cash Flow 71.05
Particulars MAR 2020 (Values in Cr)
Net Income 37.48
Cash from Operations 16.37
Cash from Investing -12.07
Cash from Financing 4.64
Net change in Cash 3.43
Free Cash Flow 33.02
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 87.50
  • 26 Days 83.10
  • 10 Days 86.00
  • 50 Days 82.90
  • 12 Days 85.30
  • 100 Days 77.60
  • 20 Days 82.80
  • 200 Days 55.30
89.12
PIVOT
First Resistance 90.93
Second Resistance 93.51
Third Resistance 95.32
First Support 86.54
Second Support 84.73
Third Support 82.15
RSI 61.15
MACD 2.23
Commodity Channel Index (CCI) 69.49
ADX 21.35
Williams % R -25.69

Over 1 Month

down

15.35

Over 3 Months

down

-6.94

Over 6 Months

down

67.39

Over 1 Year

down

95.57

Over 3 Years

down

15.49

Over 5 Years

down

41.88

MOREPEN LAB. LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MOREPEN LAB. LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
60.57
Promoter Holdings
35.65
FII
2.07
DII
1.69
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Pinfold Overseas Limited Public Shareholding 3.853E7 7.03
Scope Credits And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.5575405E7 2.84
Concept Credits And Consultants Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.5347724E7 2.8
Brook Investments And Financial Services Pvt. Ltd Shareholding of Promoter and Promoter Group 1.5159252E7 2.77
Solitary Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.5114045E7 2.76
Solace Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.508279E7 2.75
React Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.4942134E7 2.73
Mid Med Financial Services And Investments Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.4973813E7 2.73
Epitome Holdings Pvt.ltd. Shareholding of Promoter and Promoter Group 1.450082E7 2.65
Seed Securities And Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.432878E7 2.61
Square Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.4102075E7 2.57
Morepen Laboratories Limited Public Shareholding 5576214.0 1.02
Sushil Suri Shareholding of Promoter and Promoter Group 5501510.0 1.0
Anju Suri Shareholding of Promoter and Promoter Group 5186369.0 0.95
Liquid Holdings Pvt. Ltd. Shareholding of Promoter and Promoter Group 5003000.0 0.91
Sonia Pankaj Bajaj Shareholding of Promoter and Promoter Group 3679718.0 0.67
Sanjay Suri Shareholding of Promoter and Promoter Group 3417240.0 0.62
Sunita Suri Shareholding of Promoter and Promoter Group 3192240.0 0.58
Varun Suri Shareholding of Promoter and Promoter Group 3052357.0 0.56
Mamta Suri Shareholding of Promoter and Promoter Group 3004000.0 0.55
Sanjay Suri (sanjay Suri Sons Huf) Shareholding of Promoter and Promoter Group 2100000.0 0.38
Shalu Suri Shareholding of Promoter and Promoter Group 2052250.0 0.37
Anubhav Suri (arun Suri Sons Huf) Shareholding of Promoter and Promoter Group 1500000.0 0.27
Sushil Suri (sushil Suri Sons Huf) Shareholding of Promoter and Promoter Group 1201560.0 0.22
Gulfy Malhotra Shareholding of Promoter and Promoter Group 1150000.0 0.21
Kanak Suri Shareholding of Promoter and Promoter Group 997060.0 0.18
Rajas Suri (kb Suri Sons Huf) Shareholding of Promoter and Promoter Group 972830.0 0.18
Anubhav Suri Shareholding of Promoter and Promoter Group 782134.0 0.14
Aanandi Suri Shareholding of Promoter and Promoter Group 750000.0 0.14
Master Arjun Suri Shareholding of Promoter and Promoter Group 697060.0 0.13
Aanchal Suri Shareholding of Promoter and Promoter Group 685922.0 0.13
Sara Suri Shareholding of Promoter and Promoter Group 705000.0 0.13
P.l. Suri Shareholding of Promoter and Promoter Group 400000.0 0.07
Rajas Suri Shareholding of Promoter and Promoter Group 155000.0 0.03
Aakriti Suri Shareholding of Promoter and Promoter Group 55000.0 0.01
Kanta Suri Shareholding of Promoter and Promoter Group 1510.0 0.0
Praduman Lal Suri Huf Shareholding of Promoter and Promoter Group 2990.0 0.0

MOREPEN LAB. LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2000-11-07 10.0 2.0 2000-11-22 2000-11-06 10.0 2.0 2000-11-22

Morepen Lab share result highlights

In the second quarter of fiscal year 2024-25, Morepen Laboratories Limited reported a consolidated net profit of ₹21.26 crore, marking a 45% increase from ₹14.63 crore in the previous quarter. Revenue from operations rose by 5.2% quarter-on-quarter to ₹421.77 crore. The company's EBITDA margin improved to 12.25%, reflecting enhanced operational efficiency. These robust financial results have positively influenced the Morepen Lab share price, reflecting increased investor confidence.

Morepen Lab share annual reports

The 2023-24 annual report of Morepen Laboratories Limited provides comprehensive insights into its financial performance and strategic initiatives. The company achieved a total income of ₹1,744.6 crore, registering a growth of 7.7% from the previous year. The report highlights Morepen's focus on expanding its product portfolio, enhancing operational efficiency, and implementing cost optimisation measures. These efforts have contributed to a stable Morepen Laboratories share price by showcasing the company's commitment to growth and profitability.

Morepen Lab share dividend

For the fiscal year 2023-24, Morepen Laboratories Limited declared a total dividend of ₹1.50 per share, reflecting its commitment to returning value to shareholders. This consistent dividend payout, supported by strong financial performance, has positively impacted the Morepen Lab share price by enhancing investor confidence.

About MOREPEN LAB. LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MOREPEN LAB. LTD

Learn More About Stocks

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Morepen Laboratories Ltd?

Answer Field

The share price of Morepen Laboratories Ltd for NSE is ₹ 87.13 and for BSE is ₹ 87.12.

What is the Market Cap of Morepen Laboratories Ltd?

Answer Field

The market cap of Morepen Laboratories Ltd for NSE is ₹ 44,53.81 Cr. and for BSE is ₹ 44,53.30 Cr. as of now.

What is the 52 Week High and Low of Morepen Laboratories Ltd?

Answer Field

The 52 Week High and Low of Morepen Laboratories Ltd for NSE is ₹ 100.90 and ₹ 38.55 and for BSE is ₹ 100.80 and ₹ 38.56.

How to Buy Morepen Laboratories Ltd share?

Answer Field

You can trade in Morepen Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Morepen Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 95.57%.

What is the Current Share Price of Morepen Laboratories Ltd?

Answer Field

Morepen Laboratories Ltd share price is for NSE ₹ 87.13 & for BSE ₹ 87.12 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Morepen Laboratories Ltd Share?

Answer Field

The market cap of Morepen Laboratories Ltd for NSE ₹ 44,53.81 & for BSE ₹ 44,53.30 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Morepen Laboratories Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Morepen Laboratories Ltd share is 33.64.

What is the PB ratio of Morepen Laboratories Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Morepen Laboratories Ltd share is 20.95.

How to Buy Morepen Laboratories Ltd Share?

Answer Field

You can trade in Morepen Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Morepen Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Morepen Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Morepen Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Popular FAQs

1. Who is the CEO of Morepen Lab Ltd?

As of November 2024, the Chairman and Managing Director of Morepen Laboratories Limited is Mr. Sushil Suri. He oversees the company's operations and strategic initiatives, influencing the Morepen Lab share price through effective leadership and business expansion.

 

2. When was Morepen Lab Ltd established?

Morepen Laboratories Limited was established in 1984. Over the decades, it has grown into one of India's leading pharmaceutical companies, impacting the Morepen Laboratories share price through its extensive operations and market presence.

 

3. What factors influence Morepen Lab Ltd share price fluctuations?

The Morepen Lab share price is influenced by various factors, including the company's financial performance, product launches, regulatory developments, and broader economic conditions. Additionally, market demand for pharmaceutical products, competition, and research and development outcomes play significant roles in determining share price movements.

 

4. Is Morepen Lab debt free?

No, Morepen Laboratories Limited is not entirely debt-free. The company utilises debt financing to fund its capital-intensive projects and expansion plans. However, it maintains a balanced debt-to-equity ratio, ensuring financial stability and the ability to meet its obligations without adversely affecting the Morepen Laboratories share price.

 

5. What is the CAGR of Morepen Lab share?

Over the past five years, the Compound Annual Growth Rate (CAGR) of Morepen Lab shares has been approximately 15%. This indicates a steady growth in the Morepen Lab share price, reflecting the company's consistent financial performance and strategic initiatives.

 

6. How has the Morepen Lab share price performed over the past year?

Over the past year, the Morepen Lab share price has experienced fluctuations influenced by market conditions and company performance. As of November 2024, the share price has shown a modest increase compared to the same period last year, reflecting investor confidence in the company's strategic direction and financial health.

 

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader